PMID: 7539545Jun 1, 1995Paper

Cytokine production and serum proteins in depression

Scandinavian Journal of Immunology
A SeidelH Kirchner

Abstract

One, as yet unemployed, approach to investigating immunology in depression is the assessment of the cytokine production by leucocytes, which would allow the determination of immune response under standardized conditions. Thus we measured the production of mitogen-induced cytokines (IL-1 beta, IL-2, IL-6, IL-10, interferon-gamma) and sIL-2R in a whole blood assay, and serum protein levels such as C-reactive protein (CRP), haptoglobin (Hp) and alpha 2-macroglobulin (alpha 2 M) in a longitudinal 6-week study in an attempt to assess leucocyte function during and after acute clinical stage of depression in 39 patients. Shortly after admission to hospital we found higher levels of all measured cytokines in the patients. Serum protein levels were significantly higher in the patients than in controls, and decreased over the study period. Whereas slightly elevated monokine levels in patients tended to reach control values, lymphokines showed a significant decrease over the 6 weeks as compared to baseline. These results suggest that the increase in immune activity seen at the beginning of the study may be followed by a suppressed cell-mediated immune function.

References

Apr 16, 1977·Lancet·R W BartropR Penny
Dec 1, 1992·Biological Psychiatry·P R JoyceD R Boswell
Apr 1, 1992·Journal of Psychiatric Research·M MaesP Cosyns
Feb 1, 1991·Archives of General Psychiatry·M SteinR L Trestman
May 1, 1990·Immunology Today·K James
Dec 1, 1990·Immunology Today·C M Petersen, S K Moestrup
Mar 1, 1991·The American Journal of Psychiatry·D F DarkoS Golshan
Sep 1, 1988·Psychiatry Research·D F DarkoS M Baird
Sep 1, 1987·Annals of Internal Medicine·K D DenicoffS A Rosenberg
Jan 1, 1982·Journal of Immunological Methods·H KirchnerW Digel
Sep 1, 1984·Psychiatry Research·Z KronfolG Winokur
May 1, 1984·Archives of General Psychiatry·S J SchleiferM Stein
Feb 1, 1994·Immunology Today·H Baumann, J Gauldie
Jun 1, 1993·Immunology Today·F Powrie, R L Coffman
Sep 1, 1993·Progress in Neuro-psychopharmacology & Biological Psychiatry·N MüllerR Eckstein
Nov 1, 1993·Progress in Neuro-psychopharmacology & Biological Psychiatry·C McAdams, B E Leonard
Aug 1, 1993·The American Journal of Psychiatry·M MaesE Suy
May 1, 1993·Neurochemistry International·T Bartfai, M Schultzberg
Feb 1, 1960·Journal of Neurology, Neurosurgery, and Psychiatry·M HAMILTON

❮ Previous
Next ❯

Citations

Jan 1, 1997·European Archives of Psychiatry and Clinical Neuroscience·U H FrommbergerM Berger
Oct 12, 2007·Der Nervenarzt·N Müller, M J Schwarz
Jan 1, 1996·Neuroscience and Biobehavioral Reviews·P Malek-Ahmadi
Jan 22, 2002·Journal of Psychosomatic Research·Cora WeberBurghard F Klapp
Oct 17, 1998·Journal of Psychosomatic Research·D J Newport, C B Nemeroff
Mar 14, 2001·Journal of Affective Disorders·M RothermundtH Kirchner
May 9, 1998·Journal of Affective Disorders·M HornigJ D Amsterdam
Jun 9, 1999·Journal of Affective Disorders·B H NatelsonW C Gause
May 2, 2003·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·Ja-Ryong KooBong-Ki Son
Nov 28, 2002·Progress in Neuro-psychopharmacology & Biological Psychiatry·Francesco BenedettiEnrico Smeraldi
May 10, 2002·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·M CorcosPh Jeammet
Oct 29, 2002·Brain, Behavior, and Immunity·Lucile CapuronPierre J Neveu
Oct 29, 2002·Brain, Behavior, and Immunity·H Anisman, Z Merali
Aug 30, 2003·Brain, Behavior, and Immunity·Sabine R Kunz-EbrechtAndrew Steptoe
Jun 22, 2001·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·O MikovaM Maes
Dec 15, 2000·Journal of Intellectual Disability Research : JIDR·J A TsiourisE Sersen
Aug 26, 2009·Journal of Child and Adolescent Psychopharmacology·Vilma GabbayCharles J Gonzalez
Apr 14, 2006·Current Opinion in Psychiatry·Francesco BenedettiAdriana Pontiggia
Dec 20, 2007·The Neurologist·Jeffrey A Wilken, Cynthia Sullivan
Jul 6, 2007·Psychiatry and Clinical Neurosciences·Tiao-Lai Huang, Chien-Te Lee
Sep 1, 1996·Acta Psychiatrica Scandinavica·A SeidelH Kirchner
Aug 24, 2007·Neuroimmunomodulation·Sinead M O'BrienTimothy G Dinan
Nov 22, 2013·Toxins·Alexander MunzerHubertus Himmerich
Mar 5, 2008·Clinical & Developmental Immunology·Levent SutcigilAli Sengul
Apr 13, 2000·Journal of Affective Disorders·A LinM Maes

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.